AVITA Medical Achieves Positive Topline Pivotal Trial Results for Treatment of Stable Vitiligo Using the RECELL® SystemGlobeNewsWire • 09/12/22
RECELL® System Data to be Presented at the Controversies and Conversations in Laser & Cosmetic Surgery Annual MeetingGlobeNewsWire • 08/17/22
AVITA Medical, Inc. (RCEL) CEO Dr. Mike Perry on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/12/22
Does Avita Medical Inc. (RCEL) Have the Potential to Rally 210% as Wall Street Analysts Expect?Zacks Investment Research • 06/07/22
AVITA Medical, Inc. (RCEL) CEO Mike Perry on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/13/22
RECELL® System to be Highlighted at Upcoming Music City SCALE Multidisciplinary Dermatology MeetingGlobeNewsWire • 05/09/22
RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation Annual Scientific SymposiumGlobeNewsWire • 03/23/22
AVITA Medical Announces Modification of BARDA Contract to Advance Development of RECELL® System in Soft Tissue ReconstructionGlobeNewsWire • 03/21/22
Avita Medical, Inc. Signs Agreement with Premier, Inc. to Supply the RECELL® System to Hospitals and Health Systems Across the U.S.GlobeNewsWire • 03/02/22
AVITA Medical Inc. (RCEL) CEO Mike Perry on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/01/22
AVITA Medical Reports Quarter Ending December 31, 2021, and Transition Period July 1, 2021, to December 31, 2021, Financial ResultsGlobeNewsWire • 02/28/22
The RECELL® System Receives PMDA Approval in Japan and AVITA Medical will Commercialize in Partnership with COSMOTEC, an M3 Group CompanyGlobeNewsWire • 02/23/22
AVITA Medical Announces FDA Approval of New RECELL® System with Improved Ease of UseGlobeNewsWire • 02/17/22
AVITA Medical to Announce Transition Period July 1, 2021 to December 31, 2021 Financial ResultsGlobeNewsWire • 02/15/22
AVITA Medical to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewsWire • 02/02/22
RECELL® System Data to be Presented at 44th Annual John A. Boswick Burn & Wound Care SymposiumGlobeNewsWire • 01/24/22
AVITA Medical Announces Preliminary Unaudited Results for the Quarter ended December 31, 2021GlobeNewsWire • 01/10/22
AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELL® System for Soft-Tissue ReconstructionGlobeNewsWire • 01/06/22